News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
154 Results
Type
Article (8)
Press Release (146)
Section
Business (18)
Deals (8)
Drug Development (45)
FDA (2)
Job Trends (2)
News (60)
Policy (2)
Tag
Alliances (5)
Alzheimer's disease (10)
Approvals (2)
Best Places to Work (2)
Clinical research (39)
COVID-19 (5)
Data (4)
Drug discovery (1)
Earnings (5)
Events (56)
FDA (3)
Funding (1)
Healthcare (29)
Infectious disease (5)
IPO (3)
Mergers & acquisitions (5)
Neurodegenerative disease (1)
Neuroscience (19)
NextGen: Class of 2026 (1)
Parkinson's disease (9)
Patient recruitment (1)
People (9)
Phase 1 (5)
Phase 2 (28)
Phase 3 (15)
Pipeline (1)
Regulatory (3)
Research institute (1)
Date
Last 365 days (15)
2026 (1)
2025 (14)
2024 (32)
2023 (31)
2022 (19)
2021 (36)
2020 (8)
2019 (4)
2018 (1)
2017 (1)
2016 (1)
2013 (1)
Location
Asia (9)
California (1)
Europe (10)
Massachusetts (2)
Nevada (29)
United States (3)
154 Results for "biovie".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease
January 8, 2026
·
5 min read
Press Releases
BioVie to Host Live Investor Webinar and Q&A on Oct. 8
September 29, 2025
·
3 min read
Press Releases
BioVie Inc. Announces Closing of $12 Million Public Offering
August 12, 2025
·
4 min read
Press Releases
BioVie Inc. Announces Pricing of $12 Million Public Offering
August 8, 2025
·
5 min read
BioMidwest
Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on June 26
BioVie Inc. is pleased to invite investors to a webinar on June 26, 2024, at 4:15 p.m. ET.
June 12, 2024
·
3 min read
Press Releases
BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth
May 6, 2025
·
11 min read
Press Releases
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
June 25, 2025
·
8 min read
Press Releases
BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)
June 26, 2025
·
10 min read
Press Releases
BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded
November 5, 2024
·
4 min read
Press Releases
BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes
August 14, 2025
·
8 min read
1 of 16
Next
